Results 61 to 70 of about 4,527,439 (244)
Erupção a fármaco com eosinofilia e sintomas sistémicos (síndrome DRESS).
Adverse cutaneous reactions to drugs are frequent, affecting from 2% to 3% of all hospitalized patients. But only about 2% of these cutaneous reactions are severe and seldom are fatal.
Inês Lobo +4 more
doaj +1 more source
Development and inter-rater reliability of the Liverpool adverse drug reaction causality assessment tool. [PDF]
To develop and test a new adverse drug reaction (ADR) causality assessment tool (CAT)
Smyth, RL +8 more
core
Adverse cutaneous drug eruptions: current understanding
Adverse cutaneous drug reactions are recognized as being major health problems worldwide causing considerable costs for health care systems. Most adverse cutaneous drug reactions follow a benign course; however, up to 2 % of all adverse cutaneous drug ...
Schmid-Grendelmeier, P +8 more
core +1 more source
OAF Blocks SIAH1‐Mediated Degradation of SCPX, a Therapeutic Strategy for MASLD
This study shows OAF directly binds to SCPX and inhibits its interaction with the E3 ligase SIAH1, thereby protecting SCPX from ubiquitin‐dependent degradation and stabilizing its levels. This OAF‐SCPX axis represents a novel pathway in lipid homeostasis, highlighting OAF as a promising therapeutic candidate for MASLD.
Zongxi Li +11 more
wiley +1 more source
Clinical Manifestations and Prognosis Factors in Severe Cutaneous Adverse Drug Reaction (Scadr) [PDF]
Severe Cutaneous adverse drug reaction (SCADR) is a severe skin reaction due to the use of drugs that can be life-threatening. This article describes the clinical manifestations and prognosis factors that affect SCADR patients.
Oktavriana, Triasari +2 more
core +1 more source
CAR‐Engineered Cell Therapies Beyond Cancer: Reprogramming Fibrosis and Immune‐Mediated Inflammation
CAR‐engineered cell therapies are expanding beyond cancer toward immune resetting, pathological‐cell clearance, matrix remodeling, and microenvironmental reprogramming in autoimmune, inflammatory, and fibrotic diseases. This Review compares CAR‐T, CAR‐macrophage, and CAR‐NK platforms and proposes controllable spatiotemporal reprogramming to align ...
Peng Jun Xu +6 more
wiley +1 more source
This review systematically bridges chronic wound pathology with natural phytochemical hydrogel therapeutics. A pathology‐to‐phytochemical mechanistic mapping framework is established, linking specific wound hallmarks to targeted phytochemical interventions.
Yitao Zhou +8 more
wiley +1 more source
NSAIDS induced cutaneous adverse drug reaction – a case series [PDF]
Nonsteroidal anti-inflammatory drugs (NSAIDs) are common cause of cutaneous adverse reactions (CADR’s). Though there are fairly high numbers of agents which commonly cause CADR, NSAID’s holds no exception.
Sarkar, Saugata +5 more
core +1 more source
Phenobarbital‐Induced Toxic Epidermal Necrolysis: A Case Report
Adverse drug reactions (ADRs) can lead to severe consequences and increased morbidity and mortality rates. Phenobarbital is one of the most common anti‐epileptic drugs that has numerous adverse drug reactions, including toxic epidermal necrolysis.
Biniyam Tedla Mamo +8 more
doaj +1 more source
Severe Cutaneous Adverse Drug Reactions in Pediatric Patients: A Multicenter Study
BACKGROUND: The severe cutaneous adverse drug reactions (SCARs) are rare but could be life-threatening. These include drug reaction with eosinophilia and systemic symptoms (DRESS), Stevens-Johnson syndrome, toxic epidermal necrolysis (TEN), and acute ...
Betul Buyuktiryaki +27 more
core +1 more source

